1433280-23-9

Basic information

• Product Name: (R)-4-[5-(4-bromo-2-fluoro-5-trifluoromethoxy-phenylcarbamoyl)-pyridin-2-yl]-3-methyl-piperazine-1-carboxylic acid tert-butyl ester
• Synonyms: (R)-4-[5-(4-bromo-2-fluoro-5-trifluoromethoxy-phenylcarbamoyl)-pyridin-2-yl]-3-methyl-piperazine-1-carboxylic acid tert-butyl ester
• CAS NO: 1433280-23-9
• Molecular Weight: 577.374
• Mol File: 1433280-23-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (R)-4-[5-(4-bromo-2-fluoro-5-trifluoromethoxy-phenylcarbamoyl)-pyridin-2-yl]-3-methyl-piperazine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-4-[5-(4-bromo-2-fluoro-5-trifluoromethoxy-phenylcarbamoyl)-pyridin-2-yl]-3-methyl-piperazine-1-carboxylic acid tert-butyl ester(1433280-23-9)
• EPA Substance Registry System: (R)-4-[5-(4-bromo-2-fluoro-5-trifluoromethoxy-phenylcarbamoyl)-pyridin-2-yl]-3-methyl-piperazine-1-carboxylic acid tert-butyl ester(1433280-23-9)

Safety Data

• Hazardous Substances Data: 1433280-23-9(Hazardous Substances Data)

Upstream product

• 65352-94-5 6-fluoronicotinoyl chloride 
• 116369-23-4 2-fluoro-5-(trifluoromethoxy)aniline 
• 1374892-24-6 N-(4-bromo-2-fluoro-5-trifluoromethoxy-phenyl)-6-fluoro-nicotinamide 
• 163765-44-4 (R)-tert-butyl 3-methylpiperazine-1-carboxylate 
• 116367-67-0 4-bromo-2-fluoro-5-trifluoromethoxy-phenylamine 

Downstream Products

• 1433281-07-2 (R)-4-[5-(5-fluoro-4'-{2-[(2S,4S)-1-((S)-2-methoxycarbonylamino-3-methyl-butyryl)-4-methyl-pyrrolidin-2-yl]-1H-imidazol-4-yl}-2-trifluoromethoxy-biphenyl-4-ylcarbamoyl)-pyridin-2-yl]-3-methyl-piperazine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

HEPATITIS C VIRUS INHIBITORS

The invention provides compounds of formula (I): wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are inhibitors of replication of the hepatitis C virus. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat hepatitis C viral infections, and processes and intermediates useful for preparing such compounds.